Literature DB >> 23879473

Mitochondria-targeted peptides prevent on contrast-induced acute kidney injury in the rats with hypercholesterolemia.

Shao-Bin Duan1, Shi-Kun Yang, Qiao-Yan Zhou, Peng Pan, Hui Zhang, Fang Liu, Xiang-Qing Xu.   

Abstract

OBJECTIVE: The objective of this study is to evaluate the effect and mechanism of mitochondria-targeted peptides (MTP131 and SPI20) on contrast-induced acute kidney injury (CI-AKI) in rats with hypercholesterolemia.
METHOD: Forty SD rats were randomly divided into normal diet group (NN, n = 8) and high cholesterol supplemented dietary group (HN, n = 32). At the end of 8 weeks, the group HN was divided into four subgroups. All Rats were given injection of either diatrizoate (10 mL/kg) or equal volume of normal saline, the rats pretreated with MTP131 or SPI20 were given injection with MTP131 or SPI 20 (3 mg/kg) by peritoneal cavity for 3 times. Blood, urine and renal tissue samples were prepared to determine biochemical parameters. The renal pathological changes were evaluated by hematoxylin and eosin staining and scored semiquantitatively, The protein expression of renal NOX4 was also measured by Western blotting.
RESULTS: In diatrizoate-injected rats, Serum creatinine (Scr), fractional excretion of sodium (FeNa%), fractional excretion of potassium (FeK%), pathological scores, renal malondialdehyde (MDA) content, the NADPH oxidase activity and the expression of NOX4 in kidney tissue were significantly increased (p < 0.01). In the groups pretreated with MTP131 or SPI20, the levels of Scr, FeNa%, FeK%, MDA content and NADPH oxidase activity in renal tissue decreased (p < 0.01), the levels of renal super oxygen dehydrogenises and ATPase activity increased (p < 0.01). The renal injuries induced by contrast media (CM) were alleviated.
CONCLUSION: MTP131 and SPI20 might protect acute kidney injury induced by CM in rats with hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23879473     DOI: 10.3109/0886022X.2013.815107

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  11 in total

Review 1.  Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Claudia Loganes; Liza Vecchi Brumatti; Alessandra Knowles; Sabrine Bilel; Alberto Tommasini; Roberta Bortul; Marina Zweyer
Journal:  Int J Mol Sci       Date:  2015-12-30       Impact factor: 5.923

Review 2.  First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.

Authors:  Hazel H Szeto
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 3.  Serendipity and the discovery of novel compounds that restore mitochondrial plasticity.

Authors:  H H Szeto; A V Birk
Journal:  Clin Pharmacol Ther       Date:  2014-09-04       Impact factor: 6.875

4.  Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.

Authors:  Hazel H Szeto; Shaoyi Liu; Yi Soong; Surya V Seshan; Leona Cohen-Gould; Viacheslav Manichev; Leonard C Feldman; Torgny Gustafsson
Journal:  J Am Soc Nephrol       Date:  2016-11-23       Impact factor: 10.121

5.  Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease.

Authors:  Alfonso Eirin; Behzad Ebrahimi; Xin Zhang; Xiang-Yang Zhu; John R Woollard; Quan He; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Cardiovasc Res       Date:  2014-06-19       Impact factor: 10.787

Review 6.  The Emerging Role of Mitochondrial Targeting in Kidney Disease.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Handb Exp Pharmacol       Date:  2017

7.  Aged kidney: can we protect it? Autophagy, mitochondria and mechanisms of ischemic preconditioning.

Authors:  Stanislovas S Jankauskas; Denis N Silachev; Nadezda V Andrianova; Irina B Pevzner; Ljubava D Zorova; Vasily A Popkov; Egor Y Plotnikov; Dmitry B Zorov
Journal:  Cell Cycle       Date:  2018-07-25       Impact factor: 4.534

8.  Preventive effect of pentoxifylline on contrast-induced acute kidney injury in hypercholesterolemic rats.

Authors:  Shi-Kun Yang; Shao-Bin Duan; Peng Pan; Xiang-Qing Xu; Na Liu; Jun Xu
Journal:  Exp Ther Med       Date:  2014-12-15       Impact factor: 2.447

Review 9.  Protective Role for Antioxidants in Acute Kidney Disease.

Authors:  Joanne M Dennis; Paul K Witting
Journal:  Nutrients       Date:  2017-07-07       Impact factor: 5.717

10.  Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice.

Authors:  Shi-Kun Yang; Ai-Mei Li; Ya-Chun Han; Can-Hui Peng; Na Song; Ming Yang; Ming Zhan; Ling-Feng Zeng; Pan-Ai Song; Wei Zhang; Shi-Qi Tang; Hao Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-06-02       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.